EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access

Safety and Prognostic Implications of Mechanical Circulatory Support‐Assisted Transcatheter Edge‐to‐Edge Repair: The OCEAN‐Mitral Registry

Shuhei Tanaka iD, Teruhiko Imamura iD, Ryuichi Ushijima iD, Makiko Nakamura, Nobuyuki Fukuda, Hiroshi Ueno iD, Koichiro Kinugawa, Masanori Yamamoto iD, Shunsuke Kubo iD, Yuki Izumi iD, Mike Saji iD, Masahiko Asami iD und 17 weitere

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.125.042785 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Shuhei Tanaka und 28 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Internal Medicine University of Toyama Japan. Hauptthemen laut MEDLINE: Cardiac Catheterization, Heart Valve Prosthesis Implantation, Mitral Valve, Mitral Valve Insufficiency. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Transcatheter edge‐to‐edge repair of the mitral valve (M‐TEER) has demonstrated promising outcomes for patients with mitral regurgitation who are unsuitable for surgical intervention. However, the clinical implications of M‐TEER in patients requiring mechanical circulatory support (MCS) for unstable hemodynamics remains unclear. This study aimed to evaluate the outcomes of MCS‐assisted M‐TEER in critically ill patients.

Methods

Consecutive patients who underwent M‐TEER for significant mitral regurgitation were identified from the Japanese multicenter OCEAN‐Mitral (Optimized Catheter Valvular Intervention–Mitral) registry. All‐cause death was compared between the cohort undergoing MCS‐assisted M‐TEER and a virtual control group receiving MCS alone without undergoing M‐TEER, estimated using the Seattle Heart Failure Model. Additionally, logistic regression analysis was conducted to identify factors associated with in‐hospital death following MCS‐assisted M‐TEER.

Results

A total of 3764 patients were included in the analysis (mean age, 81 years; 54.9% men; 70.1% with secondary mitral regurgitation), of whom 105 underwent MCS‐assisted M‐TEER. Procedure success exceeded 95%, irrespective of MCS use. The 1‐year mortality rate in the MCS‐assisted M‐TEER group was lower than the estimated mortality rate in the virtual control group (43.2% versus 69.5%). Factors associated with in‐hospital death included frailty, inflammation, and hypoalbuminemia. In a landmark analysis starting from discharge date, there was no statistically significant difference in cardiovascular death or heart failure hospitalization between the groups with or without the use of MCS (hazard ratio, 1.45 [95% CI, 0.93–2.26]; P =0.10).

Conclusions

MCS‐assisted M‐TEER appears to be a viable and effective therapeutic strategy for carefully selected patients with significant mitral regurgitation and unstable hemodynamics. Registration URL: https://www.umin.ac.jp/ctr/ ; Unique identifier: UMIN‐ID: UMIN000023653

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiac CatheterizationHeart Valve Prosthesis ImplantationMitral ValveMitral Valve InsufficiencyAgedAged, 80 and overFemaleHumansMaleHemodynamicsHospital MortalityJapanPrognosisRegistriesRetrospective StudiesRisk FactorsTreatment Outcome

Stichwörter der Autor:innen

mechanical circulatory supportmitral regurgitationtranscatheter edge‐to‐edge repair

Autor:innen und Institutionen

  • Second Department of Internal Medicine University of Toyama Japan.
  • Department of Cardiology Toyohashi Heart Center Toyohashi Japan.
  • Department of Cardiology Nagoya Heart Center Nagoya Japan.
  • Department of Cardiology Gifu Heart Center Gifu Japan.
  • Department of Cardiology Kurashiki Central Hospital Kurashiki Japan.
  • Department of Cardiology Sakakibara Heart Institute Tokyo Japan.

ORCID-Profile: Shuhei Tanaka, Teruhiko Imamura, Ryuichi Ushijima, Hiroshi Ueno, Masanori Yamamoto, Shunsuke Kubo, Yuki Izumi, Mike Saji, Masahiko Asami, Yusuke Enta, Shinichi Shirai, Masaki Izumo, Yusuke Watanabe, Makoto Amaki, Yohei Ohno, Gaku Nakazawa, Daisuke Hachinohe, Toshiaki Otsuka, Kentaro Hayashida

Zitieren

APA

Tanaka, S., Imamura, T., Ushijima, R., Nakamura, M., Fukuda, N., Ueno, H., Kinugawa, K., Yamamoto, M., Kubo, S., Izumi, Y., Saji, M., Asami, M., Enta, Y., Shirai, S., Izumo, M., Mizuno, S., Watanabe, Y., Amaki, M., Kodama, K., …, & OCEAN‐Mitral investigators (2025). Safety and Prognostic Implications of Mechanical Circulatory Support‐Assisted Transcatheter Edge‐to‐Edge Repair: The OCEAN‐Mitral Registry. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.042785

Vancouver

Tanaka S, Imamura T, Ushijima R, Nakamura M, Fukuda N, Ueno H, et al. Safety and Prognostic Implications of Mechanical Circulatory Support‐Assisted Transcatheter Edge‐to‐Edge Repair: The OCEAN‐Mitral Registry. Journal of the American Heart Association. 2025. doi:10.1161/jaha.125.042785

BibTeX
@article{Tanaka2025,
  author = {Tanaka, Shuhei and Imamura, Teruhiko and Ushijima, Ryuichi and Nakamura, Makiko and Fukuda, Nobuyuki and Ueno, Hiroshi and Kinugawa, Koichiro and Yamamoto, Masanori and Kubo, Shunsuke and Izumi, Yuki and Saji, Mike and Asami, Masahiko and Enta, Yusuke and Shirai, Shinichi and Izumo, Masaki and Mizuno, Shingo and Watanabe, Yusuke and Amaki, Makoto and Kodama, Kazuhisa and Otsuki, Hisao and Naganuma, Toru and Bota, Hiroki and Ohno, Yohei and Yamawaki, Masahiro and Nakazawa, Gaku and Hachinohe, Daisuke and Otsuka, Toshiaki and Hayashida, Kentaro and OCEAN‐Mitral investigators, OCEAN‐Mitral investigators},
  title = {Safety and Prognostic Implications of Mechanical Circulatory Support‐Assisted Transcatheter Edge‐to‐Edge Repair: The OCEAN‐Mitral Registry},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.125.042785}
}
Kostenlos starten →